Overview

Evaluation of Efficacy and Safety of Roxadustat for the Treatment of Chemotherapy Induced Anemia

Status:
Completed
Trial end date:
2021-04-23
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if roxadustat (also known as FG-4592) is safe and effective for the treatment of anemia in people receiving chemotherapy treatment for cancer.
Phase:
Phase 2
Details
Lead Sponsor:
FibroGen
Collaborators:
Astellas Pharma Inc
AstraZeneca
Treatments:
Glycine